Insights

Loading spinner
Gathering insights about iTeos Therapeutics

iTeos Therapeutics Tech Stack

iTeos Therapeutics uses 8 technology products and services including Adobe, RSS, SAP, and more. Explore iTeos Therapeutics's tech stack below.

  • Adobe
    Audio, Video, Graphics
  • RSS
    Content Management System
  • SAP
    Customer Relationship Management
  • Apple iCloud Mail
    Email
  • React
    Javascript Frameworks
  • Simple Machines Forum
    Message Boards
  • Yoast SEO
    Search Engines
  • Apache
    Web Servers

Media & News

iTeos Therapeutics's Email Address Formats

iTeos Therapeutics uses at least 1 format(s):
iTeos Therapeutics Email FormatsExamplePercentage
First.Last@iteostherapeutics.comJohn.Doe@iteostherapeutics.com
92%
Last@iteostherapeutics.comDoe@iteostherapeutics.com
6%
First.Middle@iteostherapeutics.comJohn.Michael@iteostherapeutics.com
1%
First.MiddleLast@iteostherapeutics.comJohn.MichaelDoe@iteostherapeutics.com
1%

Frequently Asked Questions

Where is iTeos Therapeutics's headquarters located?

Minus sign iconPlus sign icon
iTeos Therapeutics's main headquarters is located at 139 Main Street Cambridge, Massachusetts 02142 United States. The company has employees across 2 continents, including EuropeNorth America.

What is iTeos Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact iTeos Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is iTeos Therapeutics's stock symbol?

Minus sign iconPlus sign icon
iTeos Therapeutics is a publicly traded company; the company's stock symbol is ITOS.

What is iTeos Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
iTeos Therapeutics's official website is iteostherapeutics.com and has social profiles on LinkedInCrunchbase.

What is iTeos Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
iTeos Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does iTeos Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2026, iTeos Therapeutics has approximately 64 employees across 2 continents, including EuropeNorth America. Key team members include Chief Medical Officer: D. F.Chief Operating Officer: M. C.Chief Scientific Officer: Y. M.. Explore iTeos Therapeutics's employee directory with LeadIQ.

What industry does iTeos Therapeutics belong to?

Minus sign iconPlus sign icon
iTeos Therapeutics operates in the Biotechnology Research industry.

What technology does iTeos Therapeutics use?

Minus sign iconPlus sign icon
iTeos Therapeutics's tech stack includes AdobeRSSSAPApple iCloud MailReactSimple Machines ForumYoast SEOApache.

What is iTeos Therapeutics's email format?

Minus sign iconPlus sign icon
iTeos Therapeutics's email format typically follows the pattern of First.Last@iteostherapeutics.com. Find more iTeos Therapeutics email formats with LeadIQ.

How much funding has iTeos Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2026, iTeos Therapeutics has raised $501M in funding. The last funding round occurred on Apr 01, 2020 for $125M.

When was iTeos Therapeutics founded?

Minus sign iconPlus sign icon
iTeos Therapeutics was founded in 2011.

iTeos Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.

Section iconCompany Overview

Headquarters
139 Main Street Cambridge, Massachusetts 02142 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ITOS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $501M

    iTeos Therapeutics has raised a total of $501M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2020 in the amount of $125Mas a Series B.

  • $10M$25M

    iTeos Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $501M

    iTeos Therapeutics has raised a total of $501M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2020 in the amount of $125Mas a Series B.

  • $10M$25M

    iTeos Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.